Back
Tourmaline Bio 10K Form
Sell
33
TRML
Tourmaline Bio
Last Price:
28.74
Seasonality Move:
22.61%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive TRML News And Ratings
See the #1 stock for the next 7 days that we like better than TRML
TRML Financial Statistics
Sales & Book Value
| Annual Sales: | -- |
|---|---|
| Cash Flow: | $-18.01M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $13.19 |
| Price / Book: | 2.18 |
Profitability
| EPS (TTM): | -1.47040 |
|---|---|
| Net Income (TTM): | $-35.69M |
| Gross Margin: | -- |
| Return on Equity: | 0% |
| Return on Assets: | 0% |
Tourmaline Bio Earnings Forecast
Key Tourmaline Bio Financial Ratios
- Per Share Earnings over the last 2 years have been positive in 0 years.
Tourmaline Bio Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | TRML |
| Website: | tourmalinebio.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 0 |
| Quick Ratio: | 0 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
TRML Technical Analysis vs Fundamental Analysis
Sell
33
Tourmaline Bio (TRML)
is a Sell
Is Tourmaline Bio a Buy or a Sell?
-
Tourmaline Bio stock is rated a Sell
The current Tourmaline Bio [TRML] share price is $28.76. The Score for TRML is 33, which is 34% below its historic median score of 50, and infers higher risk than normal.